This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake
Ling Li, Huijia Zhao, Binyao Chen, Zhipeng Fan, Ning Li, Jiang Yue, Qifa Ye
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal Transplantation Outcomes and Treatments · Metabolism, Diabetes, and Cancer · Chronic Kidney Disease and Diabetes
Journal of Translational Medicine (2019) 17:418
10.1186/s12967-019-02170-5
The Editor has retracted this article. Initially, the authors alerted the journal that the image corresponding to the FK506+GW4064 group in Fig. 1e was inadvertently reused due to an operational oversight. However, a further investigation found further issues, such as the same image being used in Fig 1d, Fig 1f, and Fig 2a, where it is marked differently (Histone 3 and GADPH). The authors failed to provide raw unchanged images on request. The Editor has therefore lost confidence in the findings reported in this article. The authors agree to the retraction but not to the retraction wording.